{"id":353723,"date":"2026-11-19T09:37:00","date_gmt":"2026-11-19T04:07:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=353723"},"modified":"2026-11-19T09:37:00","modified_gmt":"2026-11-19T04:07:00","slug":"why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/","title":{"rendered":"Astonea Labs Ltd. (ASTONEALAB) 52 Week High Streak: Second Straight Session Near One-Year Peak"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/astonealab\/astonea-labs-ltd-share-price-today\">Astonea Labs Ltd. (ASTONEALAB)<\/a> share price is trading within 2% of its 52-week high today and stood at Rs 413, up 0.73% from the previous close. Market cap was Rs 434.63 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/astonealab\/astonea-labs-ltd-share-price-today\">Astonea Labs Ltd.<\/a> has now traded within 2% of its 52-week high for its second straight session, and the latest Univest data confirms the pattern without establishing a company-specific catalyst. ASTONEALAB last traded at Rs 413, up Rs 3 or 0.73% from the previous close, while the streak shows a cumulative move of -0.12% across the two sessions. The stock also touched a high of Rs 413 in the current move.<\/p>\n<p style=\"margin-top:0!important;\">The previous close was Rs 410, and the stock opened at Rs 413 before touching its intraday low of Rs 413 as well. That leaves the move tightly contained within a flat range on the day. With market capitalisation at Rs 434.63 crore, the repeated near-high pattern matters more than a single-day print because it shows the stock is spending more than one session near its yearly peak rather than briefly visiting it once.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#Astonea_Labs_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"Astonea Labs Ltd. 52 Week High Streak: Consecutive High Analysis\">Astonea Labs Ltd. 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#Astonea_Labs_Ltd_ASTONEALAB_Fundamental_Analysis\" title=\"Astonea Labs Ltd. (ASTONEALAB) Fundamental Analysis\">Astonea Labs Ltd. (ASTONEALAB) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_Astonea_Labs_Ltd\" title=\"Why Investors Are Watching Astonea Labs Ltd.\">Why Investors Are Watching Astonea Labs Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#About_Astonea_Labs_Ltd\" title=\"About Astonea Labs Ltd.\">About Astonea Labs Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#What_does_Astonea_Labs_Ltd_52_Week_High_Streak_mean\" title=\"What does Astonea Labs Ltd. 52 Week High Streak mean?\">What does Astonea Labs Ltd. 52 Week High Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#How_many_sessions_has_Astonea_Labs_Ltd_traded_near_its_52-week_high\" title=\"How many sessions has Astonea Labs Ltd. traded near its 52-week high?\">How many sessions has Astonea Labs Ltd. traded near its 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#What_is_the_current_Astonea_Labs_Ltd_share_price_today\" title=\"What is the current Astonea Labs Ltd. share price today?\">What is the current Astonea Labs Ltd. share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#Is_there_a_confirmed_catalyst_behind_the_repeated_near-high_move\" title=\"Is there a confirmed catalyst behind the repeated near-high move?\">Is there a confirmed catalyst behind the repeated near-high move?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#How_expensive_is_Astonea_Labs_Ltd_compared_with_its_sector\" title=\"How expensive is Astonea Labs Ltd. compared with its sector?\">How expensive is Astonea Labs Ltd. compared with its sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#What_do_the_return_ratios_show_for_Astonea_Labs_Ltd\" title=\"What do the return ratios show for Astonea Labs Ltd.?\">What do the return ratios show for Astonea Labs Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#How_does_Astonea_Labs_Ltd_compare_with_peers_on_valuation\" title=\"How does Astonea Labs Ltd. compare with peers on valuation?\">How does Astonea Labs Ltd. compare with peers on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#What_should_investors_monitor_next_in_Astonea_Labs_Ltd\" title=\"What should investors monitor next in Astonea Labs Ltd.?\">What should investors monitor next in Astonea Labs Ltd.?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-astonea-labs-ltd-share-near-52-week-consecutive-high-2026\/#Track_Astonea_Labs_Ltd_ASTONEALAB_Share_Price_on_Univest\" title=\"Track Astonea Labs Ltd. (ASTONEALAB) Share Price on Univest\">Track Astonea Labs Ltd. (ASTONEALAB) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Astonea_Labs_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>Astonea Labs Ltd. 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 413<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 410<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 3 (+0.73%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 413<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 413<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 413<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 434.63 crore<\/td>\n<\/tr>\n<\/table>\n<p>Astonea Labs Ltd. (ASTONEALAB) traded at Rs 413 versus the previous close of Rs 410, a rise of 0.73%. The stock opened at Rs 413, reached a high of Rs 413 and touched a low of Rs 413.<\/p>\n<p>Astonea Labs Ltd. Share Price Today shows ASTONEALAB trading at Rs 413, above the previous close of Rs 410 by Rs 3 or 0.73%. The stock opened at Rs 413, moved to a high of Rs 413 and a low of Rs 413, so the price action stayed compressed through the day\u2019s range. For readers tracking the Astonea Labs Ltd. stock price, the point to note is not a large intraday swing but the fact that the share price has remained close to its yearly high across more than one session.<\/p>\n<p>The company\u2019s market capitalisation stands at Rs 434.63 crore. That places the move in the context of a small-cap-sized company by value, but the chart read here is narrower: the stock is still trading near its 52-week high and the latest Univest data shows a repeat of that pattern. Because the move has been repeated rather than isolated, the Astonea Labs Ltd. share price today is being watched as part of an extended high streak rather than a one-off jump.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The repeated near-high pattern suggests persistence rather than a single sharp move, and that is the key difference between a one-session spike and a multi-session 52-week high streak. For Astonea Labs Ltd., the latest reading confirms that ASTONEALAB has stayed within 2% of its one-year peak for a second straight session. The cumulative change across the streak is still slightly negative at -0.12%, which means the stock has held near its peak zone without materially extending away from it.<\/p>\n<p>That matters because repeated highs often draw attention to the same stock price zone over several sessions. In this case, however, the latest Univest data does not establish why the move has persisted. There is no company-specific catalyst confirmed here, so the pattern should be read as a market fact rather than a story about a fresh trigger. For investors, the useful question is whether the share price can keep holding near the yearly high while fundamentals and relative valuation stay in view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Astonea_Labs_Ltd_ASTONEALAB_Fundamental_Analysis\"><\/span><strong>Astonea Labs Ltd. (ASTONEALAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 434.63 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">95.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.54x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.95%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.51%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 54.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Astonea Labs Ltd. (ASTONEALAB) fundamental metrics show P\/E 95.44x, P\/B 7.54x, ROE 11.95%, ROCE 10.51%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Astonea Labs Ltd. has a market capitalisation of Rs 434.63 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 95.44x, P\/B at 7.54x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.95% and ROCE of 10.51%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 4.3, book value per share of Rs 54.35, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 26.53x, median ROE of 10.98%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">95.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.53x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">50.75x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 1,378.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.54x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.78x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.95%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.98%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.51%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 434.63 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 789.58 crore<\/td>\n<\/tr>\n<\/table>\n<p>Astonea Labs Ltd. (ASTONEALAB) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Astonea Labs Ltd. (ASTONEALAB) has a P\/E ratio of 95.44x, which is above the benchmark median of 26.53x, a difference of +259.74%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Astonea Labs Ltd. (ASTONEALAB) has a ROE of 11.95%, which is above the benchmark median of 10.98%, a difference of +8.83%. Astonea Labs Ltd. (ASTONEALAB) has a ROCE of 10.51%, which is below the benchmark median of 13.1%, a difference of -19.77%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/albertdavd\/albert-david-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Albert David Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ALBERTDAVD<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">430.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.83<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/medicameq\/medicamen-biotech-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Medicamen Biotech Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MEDICAMEQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">413.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">35.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/jenburph\/jenburkt-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Jenburkt Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">JENBURPH<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">409.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.34<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/tll\/trident-lifeline-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Trident Lifeline Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TLL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">479.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.71<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/haleoslabs\/sms-lifesciences-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>SMS Lifesciences India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HALEOSLABS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">490.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.53<\/td>\n<\/tr>\n<\/table>\n<p>Astonea Labs Ltd. (ASTONEALAB) has a P\/E ratio of 95.44x compared with the displayed peer median of 25.11x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.95% compares with a peer median of 8.68% across the companies shown in the table. ROCE stood at 10.51% versus the displayed peer median of 10.53%, providing a capital-efficiency comparison. Astonea Labs Ltd. (ASTONEALAB) has a market capitalisation of Rs 434.63 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Astonea_Labs_Ltd\"><\/span><strong>Why Investors Are Watching Astonea Labs Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Astonea Labs Ltd. has traded within 2% of its 52-week high for a second straight session.<\/li>\n<li>The latest Univest figures show a cumulative streak move of -0.12% across the two sessions.<\/li>\n<li>ASTONEALAB last traded at Rs 413, with the day\u2019s range staying at Rs 413 to Rs 413.<\/li>\n<li>The company\u2019s P\/E ratio of 95.44 is well above the Healthcare industry median of 26.53.<\/li>\n<li>Market capitalisation stands at Rs 434.63 crore, keeping the stock in focus for Stock News and Market Update readers.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Astonea_Labs_Ltd\"><\/span><strong>About Astonea Labs Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Astonea Labs Ltd. is listed on NSE and BSE under the symbol ASTONEALAB. The company belongs to the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. In the latest market view, the stock is being followed for its near one-year high pattern, valuation premium and small-cap-sized market value. For readers tracking Astonea Labs Ltd. Share Price Today, the main context is the combination of repeated near-high trading and a valuation that sits above the industry median.<\/p>\n<p>The company\u2019s latest ratios show EPS of Rs 4.3, book value of Rs 54.35, ROE of 11.95% and ROCE of 10.51%. That set of numbers gives a basic operating and valuation frame around the Astonea Labs Ltd. stock performance, especially when compared with pharmaceutical peers in the same industry group.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Astonea_Labs_Ltd_52_Week_High_Streak_mean\"><\/span><strong>What does Astonea Labs Ltd. 52 Week High Streak mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It means Astonea Labs Ltd. has traded within 2% of its 52-week high for consecutive sessions. In this case, the streak has reached a second straight session, which keeps ASTONEALAB in the near-year-high zone.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_Astonea_Labs_Ltd_traded_near_its_52-week_high\"><\/span><strong>How many sessions has Astonea Labs Ltd. traded near its 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock has traded within 2% of its 52-week high for two consecutive sessions. The latest Univest data confirms the repeated pattern and shows that the stock remains close to its one-year peak.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_Astonea_Labs_Ltd_share_price_today\"><\/span><strong>What is the current Astonea Labs Ltd. share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ASTONEALAB last traded at Rs 413. The stock was up Rs 3, or 0.73%, versus the previous close of Rs 410, with the day\u2019s open, high and low all at Rs 413.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_there_a_confirmed_catalyst_behind_the_repeated_near-high_move\"><\/span><strong>Is there a confirmed catalyst behind the repeated near-high move?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No company-specific catalyst is confirmed by the latest Univest data. The figures show the price pattern, but they do not identify a fresh event or announcement as the reason for the repeated move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_expensive_is_Astonea_Labs_Ltd_compared_with_its_sector\"><\/span><strong>How expensive is Astonea Labs Ltd. compared with its sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock trades at a P\/E of 95.44 and a P\/B of 7.54, both above the Healthcare industry medians of 26.53 and 2.78. That places the valuation above the broader benchmark in the latest snapshot.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_return_ratios_show_for_Astonea_Labs_Ltd\"><\/span><strong>What do the return ratios show for Astonea Labs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE stands at 11.95% and ROCE at 10.51%. These figures are not uniform across the sector comparison, but they provide a useful operating backdrop for the stock\u2019s current valuation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Astonea_Labs_Ltd_compare_with_peers_on_valuation\"><\/span><strong>How does Astonea Labs Ltd. compare with peers on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Its P\/E is higher than several peers such as Albert David Ltd., Jenburkt Pharmaceuticals Ltd. and Wanbury Ltd., while also above Medicamen Biotech Ltd. and SMS Lifesciences India Ltd. That makes the stock one of the pricier names in the peer set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Astonea_Labs_Ltd\"><\/span><strong>What should investors monitor next in Astonea Labs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can watch whether the stock continues to trade near its yearly high, whether valuation remains supported by fundamentals, and how the share price behaves relative to the peer group. The repeated near-high pattern is the key market signal here.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What does Astonea Labs Ltd. 52 Week High Streak mean?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It means Astonea Labs Ltd. has traded within 2% of its 52-week high for consecutive sessions. In this case, the streak has reached a second straight session, which keeps ASTONEALAB in the near-year-high zone.\"}},{\"@type\":\"Question\",\"name\":\"How many sessions has Astonea Labs Ltd. traded near its 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock has traded within 2% of its 52-week high for two consecutive sessions. The latest Univest data confirms the repeated pattern and shows that the stock remains close to its one-year peak.\"}},{\"@type\":\"Question\",\"name\":\"What is the current Astonea Labs Ltd. share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ASTONEALAB last traded at Rs 413. The stock was up Rs 3, or 0.73%, versus the previous close of Rs 410, with the day\u2019s open, high and low all at Rs 413.\"}},{\"@type\":\"Question\",\"name\":\"Is there a confirmed catalyst behind the repeated near-high move?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No company-specific catalyst is confirmed by the latest Univest data. The figures show the price pattern, but they do not identify a fresh event or announcement as the reason for the repeated move.\"}},{\"@type\":\"Question\",\"name\":\"How expensive is Astonea Labs Ltd. compared with its sector?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock trades at a P\/E of 95.44 and a P\/B of 7.54, both above the Healthcare industry medians of 26.53 and 2.78. That places the valuation above the broader benchmark in the latest snapshot.\"}},{\"@type\":\"Question\",\"name\":\"What do the return ratios show for Astonea Labs Ltd.?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ROE stands at 11.95% and ROCE at 10.51%. These figures are not uniform across the sector comparison, but they provide a useful operating backdrop for the stock\u2019s current valuation.\"}},{\"@type\":\"Question\",\"name\":\"How does Astonea Labs Ltd. compare with peers on valuation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Its P\/E is higher than several peers such as Albert David Ltd., Jenburkt Pharmaceuticals Ltd. and Wanbury Ltd., while also above Medicamen Biotech Ltd. and SMS Lifesciences India Ltd. That makes the stock one of the pricier names in the peer set.\"}},{\"@type\":\"Question\",\"name\":\"What should investors monitor next in Astonea Labs Ltd.?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors can watch whether the stock continues to trade near its yearly high, whether valuation remains supported by fundamentals, and how the share price behaves relative to the peer group. The repeated near-high pattern is the key market signal here.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Astonea_Labs_Ltd_ASTONEALAB_Share_Price_on_Univest\"><\/span><strong>Track Astonea Labs Ltd. (ASTONEALAB) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/astonealab\/astonea-labs-ltd-share-price-today\">Astonea Labs Ltd. (ASTONEALAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Astonea Labs Ltd. Share Price trades near its 52-week high at Rs 413, marking a 0.73% rise today. Market cap stands at Rs 434.63 crore.<\/p>\n","protected":false},"author":38,"featured_media":353720,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-353723","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["353720"],"rank_math_title":["Astonea Labs Ltd. 52 Week High Streak: Near One-Year Peak"],"rank_math_description":["Astonea Labs Ltd. 52 Week High Streak extends to a second straight session, with ASTONEALAB trading near its one-year high and valuation in focus."],"rank_math_focus_keyword":["Astonea Labs Ltd. 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/astonea-labs-ltd-astonealab-52-week-high-streak-second-straight-session-near-one.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=353723"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353723\/revisions"}],"predecessor-version":[{"id":353724,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353723\/revisions\/353724"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/353720"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=353723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=353723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=353723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}